Patent · US Active

Inhibitors of JAK

US8367689B2 · kind B2 · utility

11Cited by
2References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 2010
Grant dateFeb 5, 2013
Priority date
Expiry dateMay 27, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to compounds of formula I and tautomers and pharmaceutically acceptable salts thereof which are selective inhibitors of JAK. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition JAK activity, and methods to prevent or treat a number of conditions mediated at least in part by JAK activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.